Health Condition 1: N179- Acute kidney failure, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Acute kidney injury (AKI) - AKIN stage 1 and 2 2 Systolic BP > 100 mm Hg with or without vasopressors 3 Patients on norepinephrine infusion < 10 mcg per minute dose requirement
Exclusion criteria
Exclusion criteria: 1 Pre existing CKD 2 AKI- AKIN stage 3 3 Significant Heart diseases including cardiac failure 4 Chronic liver disease 5 Significant hemodynamic instability 6 Hypotension SBP 7 Patients on norepinephrine infusion > 10 mcg per minute dose requirement 8 Patients requiring 2 or more vasopressors 9 Major electrolyte disturbances 10 Na 160 mmol/L 11 DI, SIADH and other major disorders affecting serum Na levels
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the correlation between change in urine spot sodium in response to Furosemide Stress Test (FST) and progression of acute kidney injury (AKI)Timepoint: 2,6 Hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the changes in urine spot sodium in response to Furosemide Stress Test (FST).Timepoint: 2, 6 Hrs;To assess the correlation between changes in urine spot sodium and urine output in response to Furosemide Stress Test (FST).Timepoint: 2, 6 Hrs;To assess the correlation between hourly urine output in response to Furosemide Stress Test (FST) and progression of acute kidney injury (AKI).Timepoint: 1,2 Hrs | — |
Countries
India
Contacts
AIIMS New Delhi